Mississippi Advocate Lobbied for Clinical Trial Reform
A state advocate pushed for legislation that would help cover travel and medical costs for clinical trial participants.
Updated on Sept. 26, 2026 in Cancer
Live Poll
Should federal law allow clinical trial sponsors to pay for patient travel and lodging expenses?
Ashleigh Parker, founder of the DeSoto Hope advocacy group, recently visited Washington to lobby Mississippi lawmakers for increased cancer research funding and clinical trial legislative reform. Her efforts highlight the persistent financial barriers patients face when trying to access specialized care.
Why it matters
Clinical trials are frequently located hundreds of miles from patients, making them inaccessible to many rural and low-income residents due to high travel and medical costs. This legislative push aims to bridge that gap by allowing sponsors to cover these expenses.
Nearly 200 health care and advocacy groups currently support the Clinical Trial Modernization Act. The initiative follows the passage of Mississippi's own Jill's Law earlier in 2026, though federal outcomes for this broader legislation remain under investigation.
The players
Ashleigh Parker
The founder of the DeSoto Hope advocacy group who lobbied for cancer research and trial equity.
Cindy Hyde-Smith
A U.S. Senator for Mississippi who met with advocates to discuss federal cancer research funding.
Roger Wicker
A U.S. Senator for Mississippi who was lobbied by representatives for cancer policy reform.
Trent Kelly
A U.S. Representative for Mississippi who received requests for increased clinical trial access.
The details
The proposed Clinical Trial Modernization Act aims to remove financial hurdles by permitting trial sponsors to cover patient medical cost-sharing and travel expenses. Currently, patients must often travel long distances, such as Parker's own experience traveling to Houston, Texas, for treatment, which creates significant inequity in care access.
Timeline
2019: Ashleigh Parker was diagnosed with Stage 4 colorectal cancer.
May 2025: The House version of the Clinical Trial Modernization Act was introduced.
April 2026: The Senate version of the Clinical Trial Modernization Act was introduced.
September 2026: The annual ACS CAN leadership summit and Lobby Day took place.
Health Landscape
This effort builds upon the momentum of the Clinical Trial Modernization Act, which seeks to standardize support for participants nationwide. It marks a significant departure from current models where out-of-pocket costs remain a primary barrier to trial enrollment.
If you are considering a clinical trial, ask your care team about whether your facility offers financial navigation services or support for travel costs. These discussions are worth having with your doctor to understand what assistance may currently be available to you.
The takeaway
Advocacy for clinical trial reform focuses on eliminating the financial barriers that keep patients from accessing life-saving care. Patients should track ongoing legislative updates and talk with their medical team about existing financial aid options for participating in research studies.
Further reading
For more information on navigating access to specialized treatment, visit our Cancer resources.
More information
To get involved in advocacy efforts in your area, visit the ACS CAN volunteer and advocacy opportunities portal.
Source note: This article includes information reported by DeSoto County News.
Live Poll
Should federal law allow clinical trial sponsors to pay for patient travel and lodging expenses?
